ATLANTA and LONDON, June 17 /PRNewswire/ --

IntercontinentalExchange (NYSE: ICE), a leading operator of global derivatives exchanges and over-the-counter (OTC) markets, today announced that the Commodity Futures Trading Commission (CFTC) staff has proposed conditions amending the "no-action relief letter" granted to its U.K. subsidiary, ICE Futures Europe(TM).

How is it that a statement by the Vatican has delayed my annual report to the National Institutes of Health? Not being Catholic, I generally don't pay much attention to Papal announcements, but maybe I need to start listening. Apparently back in March, the Vatican suggested that "genetic manipulations which alter DNA" are mortal sins.

Since just about everything I do in the lab involves genetic manipulations which alter DNA (in fact the only organisms in our lab which aren't genetically engineered are the people who work there), I can add one more item to my long list of reasons for why I'm headed to eternal condemnation.

But before I get to Hell, I need to submit my annual NIH Fellowship update. I have a fellowship from the National Institutes of Health, which pays my not-so-large salary. In return for the money, I tell the NIH what I've been doing every year. That's fair enough - the NIH should expect something for their money.

Everything that I have done this year, however, has involved some sort of genetic engineering - which apparently upsets the Pope. This is unfortunate, because if we eliminated all genetic engineering, essentially all biomedical research would grind to a halt. Genetic engineering, in some restricted applications, has its risks, but the vast majority of genetic engineering that goes on every day in thousands of labs all over the world is essential to our efforts to understand both basic biology and the impact of genes on our health.

STOCKHOLM, June 17 /PRNewswire/ -- Karolinska Development announced that the talk will focus on the commercialization mechanism behind the Karolinska Institutet Innovations System set up by Karolinska Institutet. Bogentoft, is CEO of Karolinska Development (KD), one of the largest life science investment companies in Europe. Using a unique highly cost effective model to commercialize innovative life science from Northern Europe KD capitalizes on the value appreciation generated by bringing very early projects to proof of concept.

This talk will cover the key points that have enabled KD to build a portfolio in less than 5 years that, has three companies with products on the market; four with compounds at phase II and five with compounds at phase I.

SEATTLE, June 17 /PRNewswire/ --

- Opens New Headquarters in The Hague, Expands Presence and Operations in New Countries, Signs Multiple Channel Partners Throughout Europe, Localizes Network Security Solutions

WatchGuard(R) Technologies, a global provider of network security solutions, today announced that it is rapidly expanding its market presence throughout Europe, marked by a series of substantive developments. This includes the opening of a new EMEA (Europe, Middle East and Africa) corporate headquarters in The Hague, expansion of sales and operations into several countries, recruitment of new distributors and multiple new channel resellers, and localization of its award-winning unified threat management (UTM) solutions for France.

MENLO PARK, California and LAGUNA HILLS, California, June 17 /PRNewswire/ --

- Mark Duffell and Michael Piraino to Lead M2 Technology Partners in Acquiring Mid-Market Software and Services Businesses

BERLIN, June 17 /PRNewswire/ --

- univadis(R) Users Gain Access to BMJ Learning Content for CME and CPD

FALLS CHURCH, Virginia, June 17 /PRNewswire/ --

- Renewed Contract Realigns and Extends CSC's Relationship with Global Rail Leader

CSC (NYSE: CSC) announced today that it has renewed its information technology (IT) outsourcing agreement with Bombardier Transportation, an operating group of Bombardier Inc. The new seven-year, US$1.2 billion (euro 765 million) contract, which has an incremental value of approximately US$944 million (euro 610 million), is an extension and expansion of services that began under a 2002 contract that was valued at US$700 million over seven years.

REDWOOD CITY, California, June 17 /PRNewswire/ --

Ingenuity Systems, the leading provider of information solutions for life science researchers, today released IPA 6.3, the newest version of its pathway analysis and life sciences knowledge software. IPA now supports Affymetrix GeneChip(R) Exon Arrays and several new animal and plant species.

PARIS, June 17 /PRNewswire/ -- Alcatel-Lucent (Euronext: Paris and NYSE: ALU) today announced that it has been chosen by BT to supply its IP Service Router in an expanded role within BT's 21CN all-IP national rollout. Alcatel-Lucent is a preferred supplier to the 21CN project with the 7750 Service Router (SR) operational in many locations. The 7750 SR deployments will now be expanded in line with BT's announced customer-driven plans to extend its Ethernet services with additional points-of-presence in the metro elements of the network. The value of the contract has not been disclosed.